Banque Cantonale Vaudoise Aurinia Pharmaceuticals Inc. Transaction History

Banque Cantonale Vaudoise

$2.52 Billion
Q2 2024

A detailed history of Banque Cantonale Vaudoise transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 9,684 shares of AUPH stock, worth $70,983. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,684

Previous 4,274 126.58%

Holding current value

$70,983

Previous $21,000 161.9%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$4.81 - $5.78 $26,022 - $31,269	5,410 Added 126.58%	9,684 $55,000
Q1 2024 Apr 10, 2024	SELL	$4.93 - $9.31 $65,218 - $123,161	-13,229 Reduced 75.58%	4,274 $21,000
Q4 2023 Feb 07, 2024	SELL	$7.13 - $9.49 $31,878 - $42,429	-4,471 Reduced 20.35%	17,503 $157,000
Q3 2023 Nov 08, 2023	BUY	$7.77 - $12.27 $41,181 - $65,031	5,300 Added 31.79%	21,974 $171,000
Q2 2023 Aug 09, 2023	SELL	$8.96 - $11.69 $7,490 - $9,772	-836 Reduced 4.77%	16,674 $161,000
Q1 2023 Apr 20, 2023	SELL	$5.94 - $11.27 $38,942 - $73,886	-6,556 Reduced 27.24%	17,510 $192,000
Q4 2022 Feb 10, 2023	SELL	$4.11 - $8.14 $13,608 - $26,951	-3,311 Reduced 12.09%	24,066 $104,000
Q3 2022 Oct 17, 2022	BUY	$6.66 - $12.39 $21,884 - $40,713	3,286 Added 13.64%	27,377 $205,000
Q2 2022 Aug 02, 2022	BUY	$8.95 - $12.8 $2,183 - $3,123	244 Added 1.02%	24,091 $242,000
Q1 2022 May 09, 2022	SELL	$10.05 - $22.48 $73,244 - $163,834	-7,288 Reduced 23.41%	23,847 $296,000
Q4 2021 Feb 14, 2022	BUY	$17.78 - $33.08 $291,574 - $542,478	16,399 Added 111.29%	31,135 $712,000
Q3 2021 Oct 29, 2021	BUY	$10.93 - $23.55 $90,598 - $195,205	8,289 Added 128.57%	14,736 $326,000
Q1 2021 May 11, 2021	SELL	$12.3 - $18.73 $1,586 - $2,416	-129 Reduced 1.96%	6,447 $84,000
Q4 2020 Feb 05, 2021	SELL	$12.94 - $16.05 $2,018 - $2,503	-156 Reduced 2.32%	6,576 $91,000
Q3 2020 Oct 30, 2020	BUY	$13.19 - $16.66 $290 - $366	22 Added 0.33%	6,732 $99,000
Q2 2020 Jul 22, 2020	SELL	$14.12 - $18.33 $3,049 - $3,959	-216 Reduced 3.12%	6,710 $109,000
Q1 2020 May 14, 2020	BUY	$11.34 - $21.46 $78,540 - $148,631	6,926 New	6,926 $100,000

Others Institutions Holding AUPH

# of Institutions

191

Shares Held

56.2M

Call Options Held

499K

Put Options Held

637K

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.04B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Account

Banque Cantonale Vaudoise Aurinia Pharmaceuticals Inc. Transaction History